HZNP Share Price

Open 12.97 Change Price %
High 13.01 1 Day -0.04 -0.31
Low 12.79 1 Week -0.15 -1.15
Close 12.87 1 Month 1.00 8.42
Volume 3073233 1 Year -5.99 -31.76
52 Week High 23.44
52 Week Low 9.45
HZNP Important Levels
Resistance 2 13.07
Resistance 1 12.99
Pivot 12.89
Support 1 12.75
Support 2 12.67
NASDAQ USA Most Active Stocks
YHOO 52.58 0.00%
YHOO 52.58 0.00%
YHOO 52.58 0.00%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
ASTI 0.00 0.00%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
More..
NASDAQ USA Top Gainers Stocks
TEAR 3.34 89.77%
SCHS 0.05 66.67%
LOCM 0.09 50.00%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
TOPS 0.26 23.81%
BONT 0.80 17.65%
HAUP 0.07 16.67%
PLUG 2.44 15.09%
More..
NASDAQ USA Top Losers Stocks
DEER 0.00 -100.00%
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
AMCF 0.01 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
More..

Horizon Pharma, Inc. (NASDAQ: HZNP)

HZNP Technical Analysis 1.5
As on 21st Jul 2017 HZNP Share Price closed @ 12.87 and we RECOMMEND Sell for LONG-TERM with Stoploss of 15.91 & Buy for SHORT-TERM with Stoploss of 11.43 we also expect STOCK to react on Following IMPORTANT LEVELS.
HZNP Target for July
1st Target up-side 13.01
2nd Target up-side 13.82
3rd Target up-side 14.62
1st Target down-side 10.73
2nd Target down-side 9.92
3rd Target down-side 9.12
HZNP Other Details
Segment EQ
Market Capital 138607328.00
Sector Healthcare
Industry Drugs - Generic
Offical website http://www.horizonpharma.com
HZNP Address
HZNP
520 Lake Cook Road
Suite 520
Deerfield, IL 60015
United States
Phone: 224-383-3000
Fax: 224-383-3001
HZNP Latest News
Interactive Technical Analysis Chart Horizon Pharma, Inc. ( HZNP NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Horizon Pharma, Inc.
HZNP Business Profile
Horizon Pharma, Inc. operates as a biopharmaceutical company. It is focused on developing and commercializing medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases.